These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3721646)

  • 1. Salmon calcitonin in the treatment of bone metastases.
    Serdengeçti S; Serdengeçti K; Derman U; Berkarda B
    Int J Clin Pharmacol Res; 1986; 6(2):151-5. PubMed ID: 3721646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of synthetic salmon calcitonin in the treatment of bone lesions of the neoplastic type].
    Adamo V; Altavilla G; La Torre F; Palmara D; Tropea F
    Tumori; 1982 Feb; 68(1):63-6. PubMed ID: 7071947
    [No Abstract]   [Full Text] [Related]  

  • 3. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC; Meunier P; Terrier M; David L; Vignon G
    Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K; Schmidt UJ; Abendroth K; Ansorg H; Graner H; Lindenhayn K; Schramm G; Kalbe I
    Z Alternsforsch; 1978; 33(5):441-51. PubMed ID: 570764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcitonin nasal spray for Paget's disease of the bone].
    Luboshitzky R; Bar-Shalom R
    Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC; Harrison JE; Wilson DR
    Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
    Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
    Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment.
    Avramides A; Flores A; DeRose J; Wallach S
    J Clin Endocrinol Metab; 1976 Mar; 42(3):459-63. PubMed ID: 1254686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].
    Kuhlencordt F; Ringe JD; Kruse HP
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1620-3. PubMed ID: 7308002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmon calcitonin in cancer pain: comparison between two different treatment schedules.
    Schiraldi GF; Soresi E; Locicero S; Harari S; Scoccia S
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):229-32. PubMed ID: 3583473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calcitonin and hexestrol on urinary excretion of hydroxyproline in a patient with prostatic cancer and bone metastases.
    Matsushita Y; Hasegawa K; Sugimura R; Otomo S; Morii H
    Endocrinol Jpn; 1974 Apr; 21(2):109-13. PubMed ID: 4408206
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of salmon calcitonin treatment in bone metastases from breast cancer--a controlled trial.
    Blomqvist C; Elomaa I; Porkka L; Karonen SL; Lamberg-Allardt C
    Bone; 1988; 9(1):45-51. PubMed ID: 3288258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic activity of high-dose intravenous calcitonin in cancer patients with bone metastases.
    Tsavaris N; Kopterides P; Kosmas C; Vadiaka M; Dimitrakopoulos A; Scopelitis H; Tenta R; Vaiopoulos G; Koufos C
    Oncol Rep; 2006 Oct; 16(4):871-5. PubMed ID: 16969508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intranasal salmon calcitonin on biochemical parameters of bone turnover in postmenopausal women.
    Balint-Perić LA; Prelević GM; Beslagić Z; Petrović J
    Gynecol Endocrinol; 1994 Dec; 8(4):241-5. PubMed ID: 7709763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Salmon calcitonin in metastatic bone pain. Demonstration of acute analgesia in tumor patients].
    Kleibel F; Schmidt G
    Dtsch Med Wochenschr; 1984 Jun; 109(24):944-7. PubMed ID: 6376042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
    Tolino A; Romano L; Ronsini S; Riccio S; Montemagno U
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):358-60. PubMed ID: 8370634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human calcitonin treatment of Paget's disease of bone.
    Singer FR
    Clin Orthop Relat Res; 1977; (127):86-93. PubMed ID: 912995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One year's treatment of Paget's disease of bone by synthetic salmon calcitonin as a nasal spray.
    Reginster JY; Jeugmans-Huynen AM; Albert A; Denis D; Franchimont P
    J Bone Miner Res; 1988 Jun; 3(3):249-52. PubMed ID: 3213619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive treatment of cortical bone loss with salmon nasal calcitonin in early postmenopausal women.
    Mango D; Ricci S; Manna P; Natili G; Dell'Acqua S
    Minerva Endocrinol; 1993 Sep; 18(3):115-21. PubMed ID: 8183178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.